Trials / Completed
CompletedNCT00564811
Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom)
Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom) on the Nutritional State and Liver Biochemistry in Hepatitis C Patients.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- UPECLIN HC FM Botucatu Unesp · Academic / Other
- Sex
- All
- Age
- 24 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study was to verify the influence of Agaricus blazei (Murrill) ss. Heinemann (A. blazei) on the evolution of nutritional state and liver function in hepatitis C patients.
Detailed description
Ten patients were studied (5 - GI - not taking A. blazei - and 5 - G2 - taking A. blazei), from both sexes, with positive Anti-VHC and a healthy nutritional state, admitted into in the viral hepatitis ward. Diagnosis and treatment for hepatitis C concurred with the regulations of the Ministry of Health and nutritional evaluation was performed in 3 moments according to anthropometrical, bioimpedance, biochemical and dietary standards, with duration of 6 months. The consumption of A. blazei (10g/day) in dehydrated powder was concomitant with antiviral therapy (conventional or pegylated interferon associated with ribavirin) with duration of 5 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Agaricus blazei (Murrill) ss. Heinemann (sun mushroom) | Agaricus blazei powder, 10 grams/day, for 5 months |
Timeline
- Start date
- 2003-03-01
- Completion
- 2004-09-01
- First posted
- 2007-11-28
- Last updated
- 2015-05-29
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00564811. Inclusion in this directory is not an endorsement.